Amino acid compound and use of same for treating intrauterine growth restriction (IUGR) and for parenteral feeding of extremely premature infants

摘要

Composition comprises a mixture of amino acids or their synthetic or modified amino acid analogues or substitutes including e.g. isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine, arginine, histidine, ornithine, glycine, alanine, proline , aspartate and asparagine. The amino acid present in the mixture is present in concentrations or concentration ratios, which correspond to the physiological amino acid concentrations or concentration ratios in the blood plasma of a healthy fetus in intrauterinein the 24-34 weeks of pregnancy. Composition comprises a mixture of amino acids or their synthetic or modified amino acid analogues or substitutes including isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine, arginine, histidine, ornithine, glycine, alanine, proline , aspartate, asparagine, glutamate, glutamine, serine, tyrosine, taurine, hydroxyproline, citrulline or cysteine. The amino acid present in the mixture is present in concentrations or concentration ratios, which correspond to the physiological amino acid concentrations or concentration ratios in the blood plasma of a healthy fetus in intrauterinein the 24-34 weeks of pregnancy, where the amino acids concentrations or concentration ratios in the blood plasma of the fetus in intrauterinein are determined by collecting and analyzing the cord blood. ACTIVITY : Anabolic. MECHANISM OF ACTION : None given.